CS logo
small CS logo
Netaji Subhash Chandra Bose Cancer Research Institute

Kolkata, West Bengal, India
Hospital in Kolkata, West Bengal
3081, Nayabad Ave, New Garia, Pancha Sayar, Kolkata, West Bengal 700094

About Netaji Subhash Chandra Bose Cancer Research Institute


"We have started all our modern Redio therapy, PET, CT and Nuclear Medicine division with affordable cost in our hospital at Nayabad, Garia. Open 24 X 7."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials

Clinical Trials at Netaji Subhash Chandra Bose Cancer Research Institute


During the past decade, Netaji Subhash Chandra Bose Cancer Research Institute conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 4 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of the Long-Term Outcomes of HIV-Positive Patients
1999-03-01
2006-09-01
Completed
3,669
Prognostic Study of Metastases in Patients With Stage I, Stage II, or Stage III Non-small Cell Lung Cancer That Can Be Removed by Surgery
1999-07-01
2011-10-01
Completed
1,310
An International Study to Evaluate Recombinant Interleukin-2 in HIV Positive Patients Taking Anti-retroviral Therapy
2000-03-01
2008-11-01
Completed
4,150
Safety and Effectiveness of a Three-Drug Combination Treatment for Recently Infected or Converted HIV Patients
2006-10-01
Completed
55
Look AHEAD: Action for Health in Diabetes
2001-06-01
2020-06-30
Completed
5,145
Chemotherapy and Photodynamic Therapy in Treating Patients With Cutaneous T-Cell Lymphoma
2001-02-01
Unknown status
Study of T900607-Sodium in Previously Treated Patients With Non-Hodgkin's Lymphoma.
2002-07-01
2003-03-01
Terminated
35
S0122: Combination Chemotherapy, Radiation Therapy, and Vaccine Therapy in Limited-Stage Small Cell Lung Cancer
2003-01-01
2003-05-01
Terminated
9

Rows per page:

1–100 of 455

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Netaji Subhash Chandra Bose Cancer Research Institute" #1 sponsor was "Pfizer" with 2 trials, followed by "mAbxience Research S.L." with 2 trials sponsored, "Amgen" with 1 trials sponsored, "Christian Medical College, Vellore, India" with 1 trials sponsored and "Grifols Biologicals, LLC" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Netaji Subhash Chandra Bose Cancer Research Institute" #1 collaborator was "Actoverco" with 1 trials as a collaborator, "Astellas Pharma Inc" with 1 trials as a collaborator, "Innogene Kalbiotech Pte. Ltd" with 1 trials as a collaborator, "Instituto Grifols, S.A." with 1 trials as a collaborator and "Key Oncologics (Pty) Ltd" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.
Created with Highcharts 11.1.0Top Leading Sponsors

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Netaji Subhash Chandra Bose Cancer Research Institute


According to Clinical.Site data, the most researched conditions in "Netaji Subhash Chandra Bose Cancer Research Institute" are "Acute Promyelocytic Leukemia" (1 trials), "Diffuse Large B-cell Lymphoma" (1 trials), "Idiopathic Thrombocytopenic Purpura" (1 trials), "Metastatic Castrate Sensitive Prostate Cancer" (1 trials) and "Metastatic Non Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Netaji Subhash Chandra Bose Cancer Research Institute" in a lesser frequency.

Clinical Trials Intervention Types at Netaji Subhash Chandra Bose Cancer Research Institute


Most popular intervention types in "Netaji Subhash Chandra Bose Cancer Research Institute" are "Drug" (8 trials) and "Biological" (2 trials). Other intervention types were less common.
The name of intervention was led by "Abiraterone acetate (AA)" (1 trials), "Bortezomib" (1 trials), "Carboplatin" (1 trials), "Dacomitinib" (1 trials) and "Dexamethasone" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Netaji Subhash Chandra Bose Cancer Research Institute


The vast majority of trials in "Netaji Subhash Chandra Bose Cancer Research Institute" are 8 trials for "All" genders and 2 trials for "Male" genders.

Clinical Trials Status at Netaji Subhash Chandra Bose Cancer Research Institute


Currently, there are NaN active trials in "Netaji Subhash Chandra Bose Cancer Research Institute". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Netaji Subhash Chandra Bose Cancer Research Institute, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Netaji Subhash Chandra Bose Cancer Research Institute, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By Phase

Created with Highcharts 11.1.0Trials Status